Total Payments
$6,538
2024 Payments
$2,688
Companies
21
Transactions
329
Medicare Patients
2,798
Medicare Billing
$163,383
Payment Breakdown by Category
Food & Beverage$5,978 (91.4%)
Education$559.31 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,978 | 321 | 91.4% |
| Education | $559.31 | 8 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,402 | 69 | $0 (2024) |
| Lilly USA, LLC | $808.24 | 40 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $808.03 | 52 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $690.42 | 28 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $404.78 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $378.59 | 14 | $0 (2024) |
| GENZYME CORPORATION | $304.48 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $295.48 | 8 | $0 (2024) |
| UCB, Inc. | $276.65 | 14 | $0 (2024) |
| PFIZER INC. | $228.85 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,688 | 146 | E.R. Squibb & Sons, L.L.C. ($494.60) |
| 2023 | $2,387 | 118 | Sun Pharmaceutical Industries Inc. ($450.22) |
| 2022 | $1,148 | 50 | ABBVIE INC. ($525.46) |
| 2021 | $314.71 | 15 | Lilly USA, LLC ($93.55) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.08 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.99 | General |
| Category: Immunology | ||||||
| 11/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Immunology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.06 | General |
| Category: Immunology | ||||||
| 10/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Sandoz Inc. | — | Food and Beverage | In-kind items and services | $26.56 | General |
| 10/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,421 | 2,411 | $557,045 | $86,370 |
| 2022 | 15 | 1,292 | 2,266 | $475,884 | $72,784 |
| 2021 | 4 | 85 | 215 | $25,574 | $4,229 |
Total Patients
2,798
Total Services
4,892
Medicare Billing
$163,383
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 294 | 385 | $116,655 | $20,201 | 17.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 154 | 172 | $67,424 | $10,201 | 15.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 105 | 131 | $58,426 | $9,606 | 16.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 223 | 265 | $71,550 | $9,088 | 12.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 133 | 133 | $55,727 | $9,008 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 78 | $33,696 | $5,804 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 103 | 120 | $22,680 | $3,855 | 17.0% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 19 | 198 | $18,810 | $3,347 | 17.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 145 | 719 | $25,884 | $3,193 | 12.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 23 | $16,146 | $2,242 | 13.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $17,145 | $2,223 | 13.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 22 | $13,068 | $2,028 | 15.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 37 | 37 | $11,507 | $1,683 | 14.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 19 | 20 | $9,460 | $1,289 | 13.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 24 | 35 | $7,560 | $1,139 | 15.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 13 | $7,371 | $1,046 | 14.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 15 | $3,450 | $401.86 | 11.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 18 | $486.00 | $13.51 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 283 | 361 | $109,615 | $19,221 | 17.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 241 | 284 | $76,680 | $9,665 | 12.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 148 | 148 | $62,012 | $9,362 | 15.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 101 | 114 | $50,844 | $7,472 | 14.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 117 | 119 | $46,648 | $7,185 | 15.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 34 | 37 | $21,978 | $4,025 | 18.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 173 | 935 | $33,660 | $3,975 | 11.8% |
About Derek Simpson
Derek Simpson is a Physician Assistant healthcare provider based in Danvers, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2020. The National Provider Identifier (NPI) number assigned to this provider is 1710517875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Derek Simpson has received a total of $6,538 in payments from pharmaceutical and medical device companies, with $2,688 received in 2024. These payments were reported across 329 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,978).
As a Medicare-enrolled provider, Simpson has provided services to 2,798 Medicare beneficiaries, totaling 4,892 services with total Medicare billing of $163,383. Data is available for 3 years (2021–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Danvers, MA
- Active Since 01/17/2020
- Last Updated 12/17/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1710517875
Products in Payments
- Sotyktu (Drug) $950.46
- DUPIXENT (Biological) $769.94
- SKYRIZI (Biological) $763.19
- TALTZ (Drug) $706.32
- RINVOQ (Biological) $591.52
- ILUMYA (Biological) $420.26
- TREMFYA (Drug) $378.59
- Zoryve (Drug) $273.97
- Bimzelx (Biological) $231.09
- EUCRISA (Drug) $213.58
- OPZELURA (Drug) $160.72
- Winlevi (Drug) $148.18
- VTAMA (Drug) $111.92
- OLUMIANT (Drug) $84.60
- Cimzia (Drug) $45.56
- COSENTYX (Drug) $45.44
- SPEVIGO (Drug) $30.10
- Otezla (Drug) $26.87
- COSENTYX (Biological) $24.05
- XTRAC (Device) $23.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Danvers
Mrs. Jessica Howie, Pa-C, PA-C
Physician Assistant — Payments: $14,744
Physician Assistant $14,744
Mr. Matthew Galvin, Pa-C, PA-C
Physician Assistant — Payments: $8,515
Physician Assistant $8,515
Carla Brogna, Pa, PA
Physician Assistant — Payments: $5,428
Physician Assistant $5,428
Hannah Littlefield, Pa-C, PA-C
Physician Assistant — Payments: $5,362
Physician Assistant $5,362
Jazmine Kendrick
Physician Assistant — Payments: $5,104
Physician Assistant $5,104
Ms. Karen Fielding, Pa-C, PA-C
Physician Assistant — Payments: $3,845
Physician Assistant $3,845